Panel discussion featuring Bill Hambrecht, founder, chairman and CEO, W. R. Hambrecht and Co., John Koten, Mansueto Ventures (publisher of Inc. & Fast Company), Ramana Nanda, Harvard Business School, Antoinette Schoar, …

Akebia Therapeutics, Inc., a pharmaceutical discovery and development company focused on anemia and vascular disorders, has successfully completed a phase 1b study for AKB-6548 in healthy volunteers. Akebia also announced it has completed the second tranche of the Series A $16 million financing round announced in July 2009.

A recent article WSJ.com reported that Angel investor groups are seeing an increase in new members, “as high-net-worth individuals seek safety in numbers and access to quality deal flow.”
The article mentions John Huston, a …

According to a recent article in the San Francisco Chronicle, the biotech industry raised a record $55.8 billion in 2009, a jump of 85 percent over the $30.1 billion recorded in 2008.  This, despite hesitant …